A phenotype-sensitizing Apoe-deficient genetic background reveals novel atherosclerosis predisposition loci in the

Hayes M Dansky1, Pei Shu, M Donavan

  • 1Laboratory of Biochemical Genetics and Metabolism, The Rockefeller University, New York, New York 10021, USA.

Genetics
|April 26, 2002
PubMed

Insights

Researchers identified new genetic factors influencing atherosclerosis beyond cholesterol. These findings in Apoe-deficient mice reveal novel susceptibility loci, offering new therapeutic targets for cardiovascular disease.

Area of Science:

  • Cardiovascular Research
  • Genetics
  • Immunology

Background:

  • Atherosclerosis treatments primarily target cholesterol, but efficacy varies among patients.
  • This suggests other genetic factors contribute to atherosclerosis predisposition.
  • Apolipoprotein E (Apoe) deficiency is a key model for studying atherosclerosis.

Purpose of the Study:

  • To identify genetic loci regulating atherosclerosis susceptibility independent of cholesterol levels.
  • To investigate mechanisms of atherosclerosis beyond lipoprotein regulation.
  • To discover novel genetic targets for atherosclerosis intervention.

Main Methods:

  • Quantitative trait locus (QTL) analysis was performed on two inbred strains of Apoe-deficient mice.
  • Crosses between C57BL/6 and FVB/N Apoe-deficient mice were utilized.
  • Statistical analysis identified significant and suggestive genetic loci influencing lesion size.

Main Results:

  • A significant locus on chromosome 10 explained 19% of the variance in lesion area, independent of cholesterol.
  • Two suggestive loci on chromosomes 14 and 19 each accounted for 7-8% of lesion variance.
  • Five loci affecting lesion size, but not lipoprotein levels, were identified and partially confirmed in a separate cross.

Conclusions:

  • Previously unreported atherosclerosis susceptibility loci have been identified.
  • These loci are distinct from those linked to lipoprotein levels.
  • The findings provide new insights into the genetic basis of atherosclerosis and potential therapeutic avenues.